203 related articles for article (PubMed ID: 20004585)
1. Synthesis, anti-HIV and anti-oxidant activities of caffeoyl 5,6-anhydroquinic acid derivatives.
Ma CM; Kawahata T; Hattori M; Otake T; Wang L; Daneshtalab M
Bioorg Med Chem; 2010 Jan; 18(2):863-9. PubMed ID: 20004585
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anti-fungal and 1,3-β-D-glucan synthase inhibitory activities of caffeic and quinic acid derivatives.
Ma CM; Abe T; Komiyama T; Wang W; Hattori M; Daneshtalab M
Bioorg Med Chem; 2010 Oct; 18(19):7009-14. PubMed ID: 20813534
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
5. First diastereoselective synthesis of methyl caffeoyl- and feruloyl-muco-quinates.
Jaiswal R; Dickman MH; Kuhnert N
Org Biomol Chem; 2012 Jul; 10(27):5266-77. PubMed ID: 22678124
[TBL] [Abstract][Full Text] [Related]
6. Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
Kim HJ; Kim EJ; Seo SH; Shin CG; Jin C; Lee YS
J Nat Prod; 2006 Apr; 69(4):600-3. PubMed ID: 16643034
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
Huang W; Miller MJ; De Clercq E; Balzarini J
Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.
Charvat TT; Lee DJ; Robinson WE; Chamberlin AR
Bioorg Med Chem; 2006 Jul; 14(13):4552-67. PubMed ID: 16524737
[TBL] [Abstract][Full Text] [Related]
9. Chicoric acid analogues as HIV-1 integrase inhibitors.
Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
[TBL] [Abstract][Full Text] [Related]
10. [Study on the structure and activity of new phenolic acid compounds from Erigeron breviscapus].
Zhang WD; Ha TB; Chen WS; Kong DY; Li HT; Wang YH; Fouraste I
Yao Xue Xue Bao; 2001 May; 36(5):360-3. PubMed ID: 12584859
[TBL] [Abstract][Full Text] [Related]
11. Discriminating between the six isomers of dicaffeoylquinic acid by LC-MS(n).
Clifford MN; Knight S; Kuhnert N
J Agric Food Chem; 2005 May; 53(10):3821-32. PubMed ID: 15884803
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV-1 activity of a novel series of 1,4,2-benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem Lett; 2006 Oct; 16(20):5298-302. PubMed ID: 16908143
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall.
Hung TM; Na M; Thuong PT; Su ND; Sok D; Song KS; Seong YH; Bae K
J Ethnopharmacol; 2006 Nov; 108(2):188-92. PubMed ID: 16809011
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of analogues of flazin, in particular, flazinamide, as promising anti-HIV agents.
Tang JG; Wang YH; Wang RR; Dong ZJ; Yang LM; Zheng YT; Liu JK
Chem Biodivers; 2008 Mar; 5(3):447-60. PubMed ID: 18357553
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of caffeic acid amide analogues as anti-platelet aggregation and anti-oxidative agents.
Hung CC; Tsai WJ; Kuo LM; Kuo YH
Bioorg Med Chem; 2005 Mar; 13(5):1791-7. PubMed ID: 15698796
[TBL] [Abstract][Full Text] [Related]
19. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem; 2006 May; 14(9):2985-93. PubMed ID: 16406643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
